MAb 3E10 therapeutic vaccine: Will start Phase II trials

MedClone Inc., Los Angeles Product: MAb 3E10 therapeutic vaccine, which gives an anti-idiotype response Indication: Nephritis associated with lupus Status: Will start Phase II trials in Switzerland in...